netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

RPB Presents Scientists at the Frontiers of Retinal Research

Remarks by RPB President Brian F. Hofland, PhD, begin at 39:20.

As part of an inaugural press conference at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology, RPB joined three other major funders of eye and vision research, both public and private, in outlining promising, groundbreaking science. 

RPB President Brian F. Hofland presented an overview of investigations conducted by leaders in the fields of retinal imaging, early disease detection, and photoreceptor regeneration and transplantation. A Q&A followed.

Download a fact sheet on the featured RPB scientists.

The press conference featured the latest research on:
• Stem cell therapy to restore vision
• Gene therapy to restore vision
• Imaging tools for the eye
• Prosthetic devices to restore vision
• Battlefield treatments for eye injuries
• Exploration into whole eye transplantation

Related News: Diabetic Retinopathy, Events, For the Media, Imaging, Macular Degeneration, Retina Disorders , Stem Cell Therapy, Top Story

Groundbreaking Gene Therapy for Retinal Disease

The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.

Read More

 

RPB and AAO Award Grants for Big Data Research to Advance Patient Care

Award recipients to use IRIS Registry database to conduct population-based studies.

Read More

 

Research to Prevent Blindness Expands Grants Program

Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.

Read More

 

Study Tests Stem Cell-based Therapy for Advanced Dry AMD

RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.

Read More

 

The National Eye Institute Turns 50

RPB celebrates five decades of sight-saving discoveries at NEI.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.